Hero

Investors

Portfolio Metrics

45 +
Approved and development-stage products
22
Blockbuster $1Bn+ therapies in portfolio
~15 Years
Portfolio weighted average royalty duration

Financial Metrics

$1.8Bn
2019A Adjusted Cash Receipts
~40%
Growth portfolio CAGR (1)
$1.6Bn
Average annual capital deployment since 2012

Notes:
(1) Reflects CAGR from 2015A-2019A; Growth Products are defined as royalties with a duration expiring after December 31, 2020; all other royalties on approved products are defined as Mature Products

Investors